We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease.
For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W
|
|
|
11-50 employees
View all MyoKardia employees
|
|
Biotechnology
|
|
1000 Sierra Point Parkway, Brisbane, California 94005, US
|
|
2012
|
|
Biotechnology, Drug Discovery, Drug Development, R&D, Therapeutics, Precision Medicine, Cardiovascular Disease, Heart Failure, Cardiomyopathy, Genetic Heart Disease
|
Jacob Hayze is the CEO of MyoKardia. To contact Jacob Hayze email at [email protected].
The decision makers in MyoKardia are Elina Lavit, James Spudich, Jaycee Martin, etc. Click to Find MyoKardia decision makers emails.
You can reach Bristol Myers Squibb by visiting their official website at www.bms.com and navigating to the 'Contact Us' section. There, you'll find options for customer service inquiries, including phone numbers and email addresses for specific departments related to cardiovascular treatments.
A staff directory is typically not publicly available for privacy and security reasons. However, you can find key contacts and leadership information on the Bristol Myers Squibb website under the 'About Us' section, which provides insights into their executive team and organizational structure.
Bristol Myers Squibb specializes in developing innovative therapies for cardiovascular diseases, including heart failure and genetic heart disease. They focus on precision medicine to tailor treatments to individual patient needs, enhancing the effectiveness of their drug development efforts.
Bristol Myers Squibb invests heavily in R&D to advance treatments for cardiovascular diseases. Their commitment includes partnerships with research institutions and a focus on drug discovery, ensuring they remain at the forefront of developing new therapies for patients with serious heart conditions.
Yes, the Bristol Myers Squibb website provides information about ongoing clinical trials for their cardiovascular treatments. You can access details about trial phases, eligibility criteria, and how to participate by visiting the 'Clinical Trials' section on their site.
Bristol Myers Squibb serves the biotechnology and pharmaceutical industries, focusing on developing therapeutics for cardiovascular diseases. Their solutions are aimed at healthcare providers, researchers, and patients, ensuring comprehensive support across the healthcare ecosystem for heart disease management.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.